key: cord-0950343-qc1iounu authors: Devnath, Popy; Al Masud, H. M. Abdullah title: The Nipah virus: A potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus-2 pandemic date: 2021-03-19 journal: New Microbes New Infect DOI: 10.1016/j.nmni.2021.100873 sha: 81e41c77c897571abfd6f9169a1a7d5d3b382564 doc_id: 950343 cord_uid: qc1iounu For centuries, zoonotic diseases have been responsible for various outbreaks resulting in the deaths of millions of people. The best example of this is the current coronavirus disease-19 (COVID-19) pandemic. Like, severe acute respiratory syndrome coronavirus, Nipah is another deadly virus, which has caused several outbreaks in the last few years. Though it causes a low number of infections, disease severity causes a higher death rate. Speculation can be done in the context of the recent COVID-19 pandemic that many countries will be unable to deal with the sudden onset of such viral outbreak. Thus, further research and attention to the virus are needed to address future outbreak(s). some viral hosts of animal species [24] . Genetic factors are also responsible for zoonotic 68 outbreaks, as many responsible viruses are RNA viruses e.g. Influenza, SARS, MERS, Ebola 69 virus [25] and recent SARS-CoV-2, and many more . It has been found that the RNA viruses are 70 the primary etiological agents of 44% of all emerging infectious diseases in the last decades, as 71 they have exceptionally shorter generation times and faster evolutionary rates which increases 72 the likelihood of infecting new host species [25] . The NiV is also an RNA virus, since RNA 73 viruses experienced mutation frequently, so we can't determine if novel NiV emerges in the next 74 5 years or later. As zoonoses possess a significant burden on animal and human health and also 75 on global economic growth, thus prioritizing such disease control mechanism is a major public 76 health issue [26] . These emerging zoonoses are a global One Health issue that requires a holistic 77 approach to control various key factors of such as socio-economic, environmental, and 78 ecological, to reduce the burden of the disease. Considering all these points, we are assuming NiV as a future outbreak agent as this viral Animal models of disease shed light on Nipah virus pathogenesis and 377 transmission Organ-and endotheliotropism of Nipah virus infections 379 in vivo and in vitro Nipah 382 virus uses leukocytes for efficient dissemination within a host Receptor-mediated cell entry of 385 paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis Dynamics of virus-receptor interactions in virus 388 binding, signaling, and endocytosis Unraveling R(0): Considerations for Public Health 391 Pandemic potential of a strain of influenza A (H1N1): early findings Estimates of the reproduction 396 number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature Comparing 399 SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet Infectious diseases High reproduction number of Middle East 402 respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi 403 Arabia and South Korea Severe acute respiratory syndrome coronavirus CoV-2): a review High Contagiousness 408 and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Nowcasting and forecasting the potential domestic and 411 international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Low-incidence, high-consequence pathogens COVID-19 vaccination in 416 immunocompromised patients A comparative analysis of 419 remdesivir and other repurposed antivirals against SARS-CoV-2 Favipiravir (T-424 705) protects against Nipah virus infection in the hamster model Nipah virus disease: A 427 rare and intractable disease Piperazine-substituted derivatives 430 of favipiravir for Nipah virus inhibition: What do in silico studies unravel? SN applied sciences 431 2021 Predicting and 433 designing therapeutics against the Nipah virus Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing 437 Human Monoclonal Antibody A neutralizing 440 human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah 441 virus infection